EQUUS - - Starting From Scratch - BY MARK HANSEN

Nor­mand Des­sureault, a 47-year vet­eran horse trainer, thought he had seen ev­ery­thing — that is, un­til two of his horses set new life­time marks and dou­bled their claim value. Nor­mand, a Florid­abased Cana­dian horse­man, dis­cov­ered “the se­cret” to im­prov­ing his horses’ speed and en­durance.

“He ran the fastest mile of his life,” Nor­mand said about one of his horses after us­ing an all-nat­u­ral blood-build­ing sup­ple­ment in the daily feed­ing rou­tine. “I put this horse on the sup­ple­ment and he went up the lad­der like crazy. All my horses are mov­ing bet­ter and faster with this sup­ple­ment. With two of my horse in par­tic­u­lar, I was check­ing their blood, hema­t­ocrits and RBC, and they were a bit low. I added a few scoops of sup­ple­ment each day for a few weeks and noted higher blood lev­els. Since then, these two horses moved up from a lower claim­ing price to a higher claim, and have won races at the higher class.”

Nor­mand added that re­cov­ery im­proved as well. “The horses used to be slug­gish the day after a race, giv­ing me the at­ti­tude of, ‘Don’t bother me; I’m sleep­ing.’ But these days, they eat good after races and they’re fired up in the stall the next day."

The sup­ple­ment Nor­mand uses is earn­ing the trust of top train­ers at the largest tracks in the U.S., Canada, Aus­tralia, and the U.A.E. They're find­ing that EPO-Equine con­tains no banned sub­stances. It’s an all-nat­u­ral blood-build­ing sup­ple­ment ac­cepted by the race­horse com­mu­nity.

But why is it im­por­tant to “build blood,” and how does this sup­ple­ment work as a blood builder? Just like in peo­ple, a horse’s mus­cles re­quire oxy­gen. Red blood cells serve as a path­way for oxy­gen - car­ry­ing cells. A higher red blood cell count = more oxy­gen = more mus­cle en­ergy. El­e­vated mus­cle en­ergy helps the horse per­form harder, faster and longer dur­ing en­durance events.

In short, the in­gre­di­ents in EPOEquine con­tain a nat­u­ral “blood­builder.” Phar­ma­col­o­gists at Biomed­i­cal Re­search Lab­o­ra­to­ries (BRL) dis­cov­ered a pro­pri­etary, horse-friendly strain of Echi­nacea an­gus­ti­fo­lia that’s as­tound­ing re­searchers and train­ers due to its blood­build­ing ca­pa­bil­i­ties.

With this spe­cial Echi­nacea strain at the helm, the uniquely po­tent, patent­pend­ing for­mula in EPO-Equine con­tains a dozen dif­fer­ent herbs, an­tiox­i­dants and anti-in­flam­ma­tory nu­tri­ents com­bined to op­ti­mize red blood cell pro­duc­tion … for re­mark­able speed, strength and stamina right out of the gate.

In a re­cent study, EPO-Equine in­creased red blood cell lev­els up to 25% in the par­tic­i­pat­ing horses.

Seven­teen horses were ran­domly fed var­ied amounts of EPO-Equine each day for 4 weeks. All of the horses showed RBC level in­creases as well as im­prove­ment in race times (timed work­outs at race tracks com­pared to base­line times, dis­tances run var­ied from 3 to 6 fur­longs). A con­trolled clin­i­cal study in race­horses, to in­ves­ti­gate the ef­fects of EPO- Equine on blood pa­ram­e­ters and ex­er­cise per­for­mance, is planned for 2012 at a U.S. equine re­search in­sti­tu­tion. The re­sults are ex­pected to be sub­mit­ted for pub­li­ca­tion in a vet­eri­nary jour­nal.

The cur­rent study re­sults are play­ing out on the track. “In base­ball, bat­ting 350 is a big deal,” said Nor­mand. “With EPOEquine, our horses have been bat­ting 450 for 4 months. I’m us­ing this prod­uct with my whole team. The re­sults are all there in the records and any­body look­ing for im­proved per­for­mance should be us­ing it.”

is very affordable at the low price of just $59.95 per jar. A BRL spokesper­son con­firmed a spe­cial of­fers to make it even more affordable. Save $180 if you have mul­ti­ple horses or you’re ready to com­mit to a larger trial with a 12-jar case for just $539.55 with FREE SHIP­PING. EPO-Equine can be or­dered at or 1-800-557-9055, and comes with a 100% money-back sat­is­fac­tion guar­an­tee.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.